Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hematopoietic and Lymphoid Cell Neoplasm: early-phase trial registry
35 of 105 indexed Hematopoietic and Lymphoid Cell Neoplasm trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #125 of 28,707 conditions by registered trial count.
105 US clinical trials · 35 currently recruiting · #125 of 28,707 conditions by registered trial count
Hematopoietic and Lymphoid Cell Neoplasm: 105 US clinical trials tracked, 35 recruiting.
Hematopoietic and Lymphoid Cell Neoplasm is the subject of 105 registered US clinical trials on ClinicalTrials.gov, 35 of them currently open to new participants. 8 are in Phase 3-4 (later-stage) and 44 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 44 of these trials.
Enrollment posture brief
Registry condition hematopoietic-and-lymphoid-cell-neoplasm
OPEN 35 | RECR 33% | LATE 8 | EARLY 44 | RANK #125 | SPON 44
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Hematopoietic and Lymphoid Cell Neoplasm lists 35 open slots (33% of 105 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hematopoietic and Lymphoid Cell Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hematopoietic and Lymphoid Cell Neoplasm is recruiting below its size-band peers.
35 of 105 indexed trials (33.3%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hematopoietic and Lymphoid Cell Neoplasm research.
M.D. Anderson Cancer Center accounts for 44 of 105 trials (41.9%). 22 distinct sponsors appear on at least one study for this condition label.
-
Typical Hematopoietic and Lymphoid Cell Neoplasm enrolment sits around 72 participants.
Median target enrolment is 72 among the 105 trials that report a genuine target (sentinel values excluded). 57 of those (54.3%) plan for fewer than 100 participants.
-
Hematopoietic and Lymphoid Cell Neoplasm research is mostly interventional.
74 interventional and 31 observational studies make up this index (70.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
105 total, page 3 of 3
Development of the Oncology Opportunity Cost Assessment Tool
Thomas Jefferson University
NCT04694911
Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy
OHSU Knight Cancer Institute
NCT04170075
Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit
M.D. Anderson Cancer Center
NCT02686411
Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Stanford University
NCT02805075
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
Jennifer Woyach
NCT04439006
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 28 |
| Phase 3 | 5 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Hematopoietic and Lymphoid Cell Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hematopoietic and Lymphoid Cell Neoplasm trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hematopoietic and Lymphoid Cell Neoplasm page
105 registered trials, 35 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 35 Hematopoietic and Lymphoid Cell Neoplasm trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Hematopoietic and Lymphoid Cell Neoplasm trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hematopoietic and Lymphoid Cell Neoplasm condition card totals 105 registered trials; most-linked intervention Questionnaire Administration; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.